{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:03Z","timestamp":1786119243090,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/bor.0b013e3282f36cf1","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T08:15:15Z","timestamp":1236240915000},"page":"173-178","source":"Crossref","is-referenced-by-count":4,"title":["Establishing outcome domains for evaluating treatment of acute and chronic gout"],"prefix":"10.1097","volume":"20","author":[{"given":"Rebecca","family":"Grainger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"R2-10-20210128","first-page":"1381","article-title":"Outcome evaluations in gout","volume":"34","author":"Schumacher","year":"2007","journal-title":"J Rheumatol"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/kem090","article-title":"Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout","volume":"46","author":"Willburger","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 9","key":"R6-10-20210128","first-page":"S679","article-title":"A phase 2 study of multiple doses of intravenous polyethylene glycol (PEG)-uricase in patients with hyperuricemia and refractory gout","volume":"52","author":"Sundy","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","article-title":"Assessment of outcome in clinical trials of gout a review of current measures","volume":"46","author":"Taylor","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R8-10-20210128","first-page":"548","article-title":"A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process","volume":"20","author":"Fried","year":"1993","journal-title":"J Rheumatol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(03)00211-7","article-title":"Delphi as a method to establish consensus for diagnostic criteria","volume":"56","author":"Graham","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1742-1241.2006.01104.x","article-title":"Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness","volume":"60","author":"Colwell","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl 9","key":"R12-10-20210128","first-page":"S105","article-title":"Preliminary identification of potential items for a definition of \u2018gout flare\u2019 using a Delphi methodology","volume":"52","author":"Grainger","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R13-10-20210128","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheumatol"},{"key":"R14-10-20210128","first-page":"2368","article-title":"Tophaceous gout: quantitative evaluation by direct physical measurement","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/art.22612","article-title":"Computed tomography measurement of tophus volume: comparison with physical measurement","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1368-5031.2006.00853.x","article-title":"Magnetic resonance imaging in the quantitative assessment of gouty tophi","volume":"60","author":"Schumacher","year":"2006","journal-title":"Int J Clin Pract"},{"key":"R18-10-20210128","first-page":"1888","article-title":"Ultrasonographic measurement of tophi as an outcome measure for chronic gout","volume":"34","author":"Perez-Ruiz","year":"2007","journal-title":"J Rheumatol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.22891","article-title":"Validation of a radiographic damage index in chronic gout","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ki.5000047","article-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","volume":"69","author":"Briet","year":"2006","journal-title":"Kidney Int"},{"issue":"25 Suppl 1","key":"R23-10-20210128","first-page":"IV31","article-title":"Surrogate markers for cardiovascular disease: functional markers","volume":"109","author":"Cohn","year":"2004","journal-title":"Circulation"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by antitumor necrosis factor-alpha therapy","volume":"114","author":"Maki-Petaja","year":"2006","journal-title":"Circulation"},{"key":"R25-10-20210128","first-page":"1810","article-title":"Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis: a randomized study","volume":"34","author":"Hafstrom","year":"2007","journal-title":"J Rheumatol"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.22003","article-title":"Development of classification and response criteria for rheumatic diseases","volume":"55","author":"Singh","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282f36cf1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:08Z","timestamp":1786038788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200803000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282f36cf1","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}